The three-story building named for Nobel Prize-winning biochemist Arthur Kornberg integrates sustainable best practices that reduce energy use by 65% relative to comparable buildings.
Madison-based Singlewire Software announced a strategic investment from funds advised by the equity firm PSG
Madison startup Allergy Amulet has raised $4.1 million in seed funding to expand the testing of its portable food allergen sensor device.
Madison-based biotechnology firm Stem Pharm has been awarded a $1.7 million SBIR grant from the National Institute of Environmental Health Sciences of the National Institutes of Health.
Achieving greater diversity in the STEM fields of science, technology, engineering, and mathematics has long been an uphill battle, but signs are pointing to steady — albeit noticeably slow — growth in the number of women being employed in the sector. Perhaps not surprisingly, Madison is helping lead the way.
The life science company’s $65 million project is expected to create approximately 50 new jobs starting this year.
Promega Biotech Ibérica, a branch of Madison-based biotechnology firm Promega, has been recognized as a business leader in Spain for the biotechnology company’s COVID-19 response.
Madison-based Cellular Logistics has been awarded a $321,000 SBIR grant from the National Institutes of Health to facilitate the assembly of Tandem HF biomaterial to assist in heart failure treatment.
Actor Jamie Foxx has joined Stand Up to Cancer and Exact Sciences for a new public service announcement to raise awareness of colorectal cancer.
Madison-based BioForward Wisconsin and BIOQuébec of Quebec, Canada will sign a memorandum of understanding on March 25 to advance cooperative relationships and promote life sciences.
Venture Debt Fund loans from the Madison Development Corp. totaling $1.6 million will go to help five growing Dane County businesses.
Fitchburg-based BellBrook Labs has been awarded a $300,000 Phase I Small Business Innovative Research grant to develop and validate HTS assays for the discovery of small-molecule antagonists of TREX1.
Madison-based Pyran Inc. has received a $1 million Phase II Small Business Innovative Research grant from the National Science Foundation to promote the company’s work to make paints and coatings from renewable sources like corn cobs.
An internally developed tool from M3 Insurance aimed at helping commercial clients facilitate a safe return to work is gaining traction.
Madison-based Wisconsin Center for Technology Commercialization (CTC) has received an award from the U.S. Small Business Administration for achieving significant economic impact in advancing small technology businesses.
Cellectar Biosciences Inc., a Madison-based company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, announced that the European Medicines Agency has adopted a positive opinion for CLR 131 orphan designation for Cellectar’s treatment for Waldenstrom’s Macroglobulinemiam, a rare blood cancer.
Exact Sciences Corp. announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology from the Translational Genomics Research Institute to expand Exact Sciences’ development of precision oncology.
California-based RefleXion Medical and HealthMyne Inc. of Madison are collaborating to use patient’s tumor data to guide cancer therapy.
Just after being elevated from CFO to president and CEO at Naviant, Michael Carr is earning praise from employees for his open and communicative style. Carr replaced his mentor, Mike Suter, the company’s founder, in Oct. 2019 and hit the ground running.
The biggest influx of technology workers in the country has been to Madison.
